Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review).

Yang, Shici; Zhu, Gaohong; He, Rui; Fang, Dong; Feng, Jiaojiao

Yang, Shici; Zhu, Gaohong; He, Rui; Fang, Dong; Feng, Jiaojiao.

Afiliación

Yang S; Department of Nuclear Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
Zhu G; Department of Nuclear Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
He R; Department of Nuclear Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
Fang D; Department of Nuclear Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
Feng J; Department of Nuclear Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.

Oncol Lett ; 26(3): 396, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37600346

Palabras clave

biomarkers; differentiating thyroid cancer; proteomics; transcriptome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Lett Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google